Nasdaq
GNTA
Genenta Science S.p.A.
- Health Care
- Italy
- Listed 2021
- 1 day
- −1.5%
- 1 month
- −18.6%
- 1 year
- −65.5%
$1.31 · Mkt cap $63.2M
At the 6 Aug 2026 close
A foreign company trading in the US through depositary receipts.
Nasdaq
Genenta Science S.p.A.
$1.31 · Mkt cap $63.2M
At the 6 Aug 2026 close
A foreign company trading in the US through depositary receipts.
Genenta Science S.p.A. trades under the ticker GNTA on Nasdaq, in the Health Care sector (Biotechnology: Biological Products (No Diagnostic Substances)). It has been listed since 2021. Its market capitalisation is $63.2M. The last closing price was $1.31, on 6 Aug 2026. No price-to-earnings ratio is shown, because it did not report positive earnings in its last annual filing. Over the past year the share price is −65.5%, and −18.6% over the past month. Returns are price returns and exclude dividends.
This page exists because GNTA is one of the shares What A Share can show you. It is not a recommendation, and its appearance here says nothing about whether the company is worth owning.